Abstract
Parkinson’s disease (PD) patients often suffer from non-motor symptoms like sleep dysregulation, mood disturbances or circadian rhythms dysfunction. The melanopsin-containing retinal ganglion cells are involved in the control and regulation of these processes and may be affected in PD, as other retinal and visual implications have been described in the disease. Number and morphology of human melanopsin-containing retinal ganglion cells were evaluated by immunohistochemistry in eyes from donors with PD or control. The Sholl number of intersections, the number of branches, and the number of terminals from the Sholl analysis were significantly reduced in PD melanopsin ganglion cells. Also, the density of these cells significantly decreased in PD compared to controls. Degeneration and impairment of the retinal melanopsin system may affect to sleep and circadian dysfunction reported in PD pathology, and its protection or stimulation may lead to better disease prospect and global quality of life of patients.
Funding Information
  • Michael J. Fox Foundation for Parkinson's Research
  • Ministerio de Educación, Cultura y Deporte (FPU 14/03166)
  • Ministerio de Economía, Industria y Competitividad, Gobierno de España (MINECO-FEDER-BFU2015-67139-R)
  • Generalitat Valenciana (Prometeo 2016/158)
  • Instituto de Salud Carlos III (ISCIII RETICS-FEDER RD16/0008/0016)
  • National Institute of Neurological Disorders and Stroke (U24 NS072026)
  • National Institute on Aging (P30 AG19610)
  • Arizona Biomedical Research Commission

This publication has 59 references indexed in Scilit: